Copyright
©2009 Baishideng.
World J Gastrointest Oncol. Oct 15, 2009; 1(1): 62-68
Published online Oct 15, 2009. doi: 10.4251/wjgo.v1.i1.62
Published online Oct 15, 2009. doi: 10.4251/wjgo.v1.i1.62
Table 4 Clinicopathological characteristics of the transitional cell carcinoma group and their relation to H-ras mutations n (%)
| Variable | n | H-ras mutation | P value | |
| Positive | Negative | |||
| Age (yr) | ||||
| ≤ 50 | 11 (22) | 1 (2) | 10 (20) | 0.479 |
| > 50 | 39 (78) | 7 (14) | 32 (64) | |
| Sex | ||||
| Male | 42 (84) | 7 (14) | 35 (70) | 0.768 |
| Female | 8 (16) | 1 (2) | 7 (14) | |
| Grade | ||||
| G2 | 18 (36) | 4 (8) | 14 (28) | 0.368 |
| G3 | 32 (64) | 4 (8) | 28 (56) | |
| Stage | ||||
| pT1 | 8 (16) | 1 (2) | 7 (14) | 0.156 |
| pT2 | 28 (56) | 4 (8) | 24 (48) | |
| pT3 | 7 (14) | 3 (6) | 4 (8) | |
| pT4 | 7 (14) | 0 (0) | 7 (14) | |
| Node status | ||||
| Positive | 6 (12) | 0 (0) | 6 (12) | 0.254 |
| Negative | 44 (88) | 8 (16) | 36 (72) | |
-
Citation: El-Chennawi FA, Auf FA, Metwally SS, Mosaad YM, Shaaban AA, El-Baz MA, Tawhid ZE, Lotfy ZF. Vascular endothelial growth factor,
p53 , and theH-ras oncogene in Egyptian patients with bladder cancer. World J Gastrointest Oncol 2009; 1(1): 62-68 - URL: https://www.wjgnet.com/1948-5204/full/v1/i1/62.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v1.i1.62